BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29391867)

  • 1. ANA-Negative Hydralazine-Induced Pericardial Effusion.
    Zeitjian V; Mehdizadeh A
    Case Rep Med; 2017; 2017():3521541. PubMed ID: 29391867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Seronegative ANA Hydralazine-Induced Lupus Presenting With Pericardial Effusion and Pleural Effusion.
    Elkholy KO; Akhtar H; Chakraborti A
    Cureus; 2020 Aug; 12(8):e9831. PubMed ID: 32953340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydralazine Induced Lupus Syndrome Presenting with Recurrent Pericardial Effusion and a Negative Antinuclear Antibody.
    Iyer P; Dirweesh A; Zijoo R
    Case Rep Rheumatol; 2017; 2017():5245904. PubMed ID: 28194293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinuclear antibody-negative lupus? An ominous presentation of hydralazine-induced lupus syndrome.
    Solomon-Tsegaye T; Treadwell EL; Obi R; Pitzalis M
    Eur J Rheumatol; 2018 Dec; 5(4):272-274. PubMed ID: 30071945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced lupus: an update on its dermatologic aspects.
    Marzano AV; Vezzoli P; Crosti C
    Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydralazine-induced pericardial effusion.
    Rahman MF; Panezai MA; Szerlip HM
    Proc (Bayl Univ Med Cent); 2019 Jul; 32(3):377-378. PubMed ID: 31384190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced lupus erythematosus.
    Sarzi-Puttini P; Atzeni F; Capsoni F; Lubrano E; Doria A
    Autoimmunity; 2005 Nov; 38(7):507-18. PubMed ID: 16373256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced lupus erythematosus in childhood: Case-based review.
    Kaya Akca U; Sener S; Batu ED; Balik Z; Basaran O; Bilginer Y; Ozen S
    Lupus; 2024 Jun; 33(7):737-748. PubMed ID: 38580326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine-Induced Lupus Syndrome Manifesting as Large Pericardial Effusion.
    Wilson NR; Chauhan S; Aisenberg G
    Cureus; 2020 Aug; 12(8):e9867. PubMed ID: 32963908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-induced lupus erythematosus].
    Atzeni F; Marrazza MG; Sarzi-Puttini P; Carrabba M
    Reumatismo; 2003; 55(3):147-54. PubMed ID: 14513113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics of Hydralazine-induced Lupus.
    Timlin H; Wu M; Crespo-Bosque M; Geetha D; Ingolia A; Haque U; Towns MC; Grader-Beck T
    Cureus; 2019 Jun; 11(6):e4996. PubMed ID: 31497427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydralazine-induced systemic lupus erythematosus presenting as pyoderma gangrenosum-like ulcers.
    Peterson LL
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):379-84. PubMed ID: 6231317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different diagnostic methods for lupus pleuritis and pericarditis: a prospective three-year study.
    Wang DY; Yang PC; Yu WL; Shiah DC; Kuo HW; Hsu NY
    J Formos Med Assoc; 2000 May; 99(5):375-80. PubMed ID: 10870326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Rare Presentation of Hydralazine-Induced Lupus in the Setting of Pericarditis With Concomitant Angioedema.
    Everett SC; Ananth D; Alejo AL; Shaub T; Gan J
    Cureus; 2023 May; 15(5):e38376. PubMed ID: 37265912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis.
    Kumar B; Strouse J; Swee M; Lenert P; Suneja M
    Semin Arthritis Rheum; 2018 Oct; 48(2):283-287. PubMed ID: 29519741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial antinuclear antibodies titre in pleural and pericardial fluid.
    Wang DY; Yang PC; Yu WL; Kuo SH; Hsu NY
    Eur Respir J; 2000 Jun; 15(6):1106-10. PubMed ID: 10885431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine-induced systemic lupus erythematosus: A case-based review.
    Álvarez-Lario B; Bártulos-Iglesias M; Colazo-Burlato M; Macarrón-Vicente J
    Eur J Rheumatol; 2019 Jan; 6(1):48-54. PubMed ID: 30388076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine-Induced Systemic Lupus Erythematosus in a Patient With Idiopathic Trigeminal Neuralgia: A Case Report.
    Kuroda H; Taniguchi K; Tsukimoto S; Imaizumi U; Komaki M; Sanuki T
    Cureus; 2023 Oct; 15(10):e47009. PubMed ID: 37965419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent.
    Subramanian S; Yajnik V; Sands BE; Cullen G; Korzenik JR
    Inflamm Bowel Dis; 2011 Jan; 17(1):99-104. PubMed ID: 20629183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.